| NCT05367388 | A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants | UNKNOWN | PHASE1 | 2022-05-20 | 2022-12 | 2022-11 |
| NCT05054543 | Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML | TERMINATED | PHASE3 | 2021-11-17 | 2024-08-22 | 2024-08-22 |
| NCT05055518 | APL-102 Capsule in Patients With Advanced Solid Tumors | SUSPENDED | PHASE1 | 2021-08-02 | 2028-12-31 | 2028-10-31 |
| NCT04839341 | Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients | COMPLETED | PHASE1 | 2021-02-24 | 2024-06-28 | 2024-06-28 |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | RECRUITING | PHASE2 | 2017-09-27 | 2026-11-30 | 2026-03-30 |